Omeprazole Teva Conseil

Omeprazole, the active ingredient in Omeprazole Teva Conseil, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to manage gastro‑reflux and related conditions in adults. GNH USA supplies Omeprazole Teva Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Omeprazole Teva Conseil is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - Erosive esophagitis: aids in mucosal healing and symptom control. - Helicobacter pylori eradication regimens (as adjunct): enhances the effectiveness of antibiotic therapy by maintaining a less acidic gastric environment.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: gas‑related bloating. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low magnesium levels. - Fracture risk: possible reduction in bone density with long‑term use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Liver enzyme elevation: potential hepatic impact.

When prescribing Omeprazole Teva Conseil, consider the following precautions: - Assess patient history: evaluate for prior hypersensitivity to PPIs. - Monitor long‑term use: assess need for continued therapy after 8‑12 weeks. - Evaluate renal function: adjust use in patients with severe kidney impairment. - Review concomitant medications: consider potential drug‑interaction risks. - Pregnancy and lactation: use only if clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines; awareness helps maintain efficacy and safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of the antiviral. - Dasatinib: lowered plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: possible reduction of phenytoin levels. - Methotrexate: increased exposure, especially at high doses. - Digoxin: modest rise in serum concentration. - Ketoconazole: reduced antifungal absorption.